# Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures

> **NCT00309335** · PHASE3 · COMPLETED · sponsor: **Novalar Pharmaceuticals, Inc.** · enrollment: 240 (—)

## Conditions studied

- Anesthesia, Dental

## Interventions

- **DRUG:** Phentolamine Mesylate (NV-101)

## Key facts

- **NCT ID:** NCT00309335
- **Lead sponsor:** Novalar Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 240 (—)
- **Last updated:** 2006-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309335, "Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00309335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*